Skip to content
Clinical Trials – home

Fakultni Nemocnice Brno

Verified siteinfo

Czechia Jihlavska 340/20, Bohunice, 625 00 Brno, Czechia

  • 127 trials recruiting
  • Plasma cell myeloma · Chronic lymphocytic leukaemia · Asthma
  • Adults and children

About Specializations

Fakultni Nemocnice Brno in Brno, Czechia specialises in clinical trials of conditions such as Plasma cell myeloma, Chronic lymphocytic leukaemia, Asthma, Plasma cell myeloma refractory, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research at Fakultni Nemocnice Brno

Clinical trials in cardiovascular diseases focus on major conditions such as acute myocardial infarction, acute coronary syndrome, atrial fibrillation, and chronic heart failure. This work is aimed at testing new ways to prevent complications, improve heart protection, and support better recovery after serious cardiac events.

  • Prevention of stroke and systemic embolism in atrial fibrillation
  • Reducing recurrent events after myocardial infarction
  • Improving treatment for heart failure with reduced ejection fraction
  • Evaluating therapies for urgent bleeding control and surgical safety

These studies reflect a strong clinical focus on safer, more effective treatment strategies for patients with high-risk heart and blood vessel conditions.

Oncology and Hematology Trials

The site is active in neoplasms and hemic and lymphatic diseases, with research spanning breast cancer, lung cancer, renal cell carcinoma, lymphoma, multiple myeloma, and myelodysplastic syndrome. These trials are generally designed to compare new treatment approaches with current standards and to improve disease control and survival.

  • Advancing care in diffuse large B-cell lymphoma and follicular lymphoma
  • Testing new options for advanced breast cancer and early breast cancer
  • Evaluating therapies for multiple myeloma and myelodysplastic syndrome
  • Studying treatment effectiveness in small cell lung cancer and non-small cell lung cancer

This research supports ongoing efforts to improve outcomes for patients with difficult-to-treat blood cancers and solid tumors.

Respiratory and Allergy Medicine

Research in respiratory tract diseases includes asthma, chronic obstructive pulmonary disease, and respiratory syncytial virus prevention. The trials aim to reduce exacerbations, lower dependence on existing medicines, and strengthen protection for vulnerable groups.

  • Improving control of severe eosinophilic asthma
  • Reducing flare-ups in oral corticosteroid-dependent asthma
  • Testing long-term management approaches for COPD
  • Supporting prevention of RSV infection in high-risk infants and children

At the Internal Cardiology Clinic, these studies add to a broader portfolio that combines chronic disease management with prevention-focused care.

Immune-Mediated and Inflammatory Diseases

Several trials address immune system diseases and inflammatory disorders such as psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and psoriasis. The main goal is to evaluate therapies that may better control symptoms, reduce inflammation, and improve daily functioning.

  • Studying treatment options for psoriatic arthritis and related joint disease
  • Evaluating care for moderate to severe chronic plaque psoriasis
  • Assessing therapies for juvenile idiopathic arthritis
  • Exploring improved control of chronic immune-driven inflammation

This area shows an emphasis on long-term symptom relief and better disease control for patients with persistent inflammatory conditions.

Neurology, Psychiatry, and Imaging Research

Clinical activity also includes nervous system diseases, multiple sclerosis, myasthenia gravis, psychoses, and imaging-related diagnostic studies. These trials are designed to improve treatment options, better understand disease behavior, and refine diagnostic evaluation.

  • Assessing long-term management in multiple sclerosis
  • Evaluating therapy for generalized myasthenia gravis
  • Studying genetic and treatment-related factors in psychosis
  • Improving magnetic resonance imaging contrast use for diagnostic assessment

These studies highlight a balanced interest in both advanced treatment and better diagnostic tools for complex neurological and psychiatric conditions.

Other Specialized Clinical Research

The trial portfolio also includes female urogenital diseases, virus diseases, and blood disorders such as haemophilia A, alongside conditions like endometriosis and uveitic macular edema. Research here often focuses on symptom relief, safety, and improved quality of life.

  • Investigating treatment for endometriosis-related pain
  • Studying prevention and management in haemophilia A
  • Evaluating care for uveitic macular edema
  • Exploring protection against viral infections in at-risk populations

Across these diverse studies, Fakultni Nemocnice Brno supports clinical research aimed at practical improvements in diagnosis, prevention, and treatment.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Jihlavska 340/20, Bohunice625 00 BrnoCzechia
Recruiting now
127 trials
Conditions studied
193
Partner status
Verified site

More sites in BrnoCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

319 clinical trials

Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Crohn's disease

Recruiting

A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Crohn's disease

Recruiting

A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement

A Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx

A Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.

Cachexia

Recruiting

A Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Visugromab
  • Sponsor:CatalYm GmbH

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.